Skip to main content

Peer Review reports

From: Delineating the role of osteoprotegerin as a marker of breast cancer risk among women with a BRCA1 mutation

Original Submission
10 Nov 2021 Submitted Original manuscript
8 Dec 2021 Author responded Author comments - Sarah Park
Resubmission - Version 2
8 Dec 2021 Submitted Manuscript version 2
3 Feb 2022 Reviewed Reviewer Report - Verena Steinke-Lange
13 Feb 2022 Reviewed Reviewer Report - Evgeny Imyanitov
2 Mar 2022 Author responded Author comments - Sarah Park
Resubmission - Version 3
2 Mar 2022 Submitted Manuscript version 3
23 Mar 2022 Reviewed Reviewer Report - Verena Steinke-Lange
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
30 Mar 2022 Editorially accepted
13 Apr 2022 Article published 10.1186/s13053-022-00223-3

You can find further information about peer review here.

Back to article page